[go: up one dir, main page]

DK0502054T3 - Aerosolfremstilling af glutathion og fremgangsmåde til forøgelse af glutathioninholdet i lunger - Google Patents

Aerosolfremstilling af glutathion og fremgangsmåde til forøgelse af glutathioninholdet i lunger

Info

Publication number
DK0502054T3
DK0502054T3 DK90917464.1T DK90917464T DK0502054T3 DK 0502054 T3 DK0502054 T3 DK 0502054T3 DK 90917464 T DK90917464 T DK 90917464T DK 0502054 T3 DK0502054 T3 DK 0502054T3
Authority
DK
Denmark
Prior art keywords
glutathione
lungs
increasing
aerosol preparation
content
Prior art date
Application number
DK90917464.1T
Other languages
English (en)
Inventor
Ronald G Crystal
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0502054T3 publication Critical patent/DK0502054T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/063Glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90917464.1T 1989-11-24 1990-11-23 Aerosolfremstilling af glutathion og fremgangsmåde til forøgelse af glutathioninholdet i lunger DK0502054T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/441,521 US5238683A (en) 1989-11-24 1989-11-24 Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs

Publications (1)

Publication Number Publication Date
DK0502054T3 true DK0502054T3 (da) 1995-06-06

Family

ID=23753204

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917464.1T DK0502054T3 (da) 1989-11-24 1990-11-23 Aerosolfremstilling af glutathion og fremgangsmåde til forøgelse af glutathioninholdet i lunger

Country Status (11)

Country Link
US (2) US5238683A (da)
EP (1) EP0502054B1 (da)
JP (1) JPH0669957B2 (da)
AT (1) ATE120087T1 (da)
AU (1) AU631711B2 (da)
CA (1) CA2069440A1 (da)
DE (1) DE69018092T2 (da)
DK (1) DK0502054T3 (da)
ES (1) ES2069755T3 (da)
GR (1) GR3015530T3 (da)
WO (1) WO1991007997A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030950A (en) * 1987-07-09 2000-02-29 Ohlenschlaeger; Gerhard Pharmaceutical therapeutic use of glutathione derivative
US5653685A (en) * 1990-10-10 1997-08-05 Lrt, Inc. Method of providing circulation via lung expansion and deflation
USRE36460E (en) * 1990-10-10 1999-12-21 Life Science Holdings, Inc. Method of providing circulation via lung expansion and deflation
US6180596B1 (en) 1995-05-18 2001-01-30 Wisconsin Alumni Research Foundation Methods of inhibiting phospholipase A2 and phospholipase A2 stimulator activities
US5658877A (en) * 1995-05-18 1997-08-19 Wisconsin Alumni Research Foundation Method to treat endotoxin effects by administration of 33 kilodalton phospholipid binding protein
AU713362B2 (en) * 1996-03-08 1999-12-02 Life Resuscitation Technologies, Inc. Liquid ventilation method and apparatus
CA2276183C (en) * 1996-12-31 2009-06-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
DE69841217D1 (de) * 1997-01-13 2009-11-19 Univ Emory Glutathion zur behandlung von influenzainfektionen
KR100585242B1 (ko) * 1998-06-23 2006-12-05 교와 핫꼬 고교 가부시끼가이샤 인플루엔자감염증치료용화합물및조성물
ES2247142T3 (es) 2000-05-02 2006-03-01 F. Hoffmann-La Roche Ag Nuevos retinoides gamma selectivos.
US7179791B2 (en) * 2001-01-11 2007-02-20 Duke University Inhibiting GS-FDH to modulate NO bioactivity
US7790762B2 (en) * 2002-10-31 2010-09-07 National Jewish Health Compounds and methods for thiol-containing compound efflux and cancer treatment
US20040087527A1 (en) * 2002-10-31 2004-05-06 Day Brian J. Methods for treatment of thiol-containing compound deficient conditions
US20080221029A1 (en) * 2002-10-31 2008-09-11 Regents Of The University Of Colorado Methods for treatment of thiol-containing compound deficient conditions
JP5112876B2 (ja) * 2004-11-07 2013-01-09 エフ. ギルフォード ティモシー 還元型グルタチオン経口投与のためのリポソーム処方物
US20090068253A1 (en) * 2005-09-06 2009-03-12 Guilford F Timothy Method for the treatment of infection with hhv-6 virus and the amelioration of symptoms related to virus using liposomal encapsulation for delivery of reduced glutathione
CA2925546C (en) 2012-10-29 2022-06-14 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US9913801B2 (en) * 2013-02-15 2018-03-13 Your Energy Systems, LLC Treatment of evolving bacterial resistance diseases including Klebsiella pneumoniae with liposomally formulated glutathione
EP3541401A4 (en) 2016-11-17 2020-07-29 Renovion, Inc. TREATMENT OF RESPIRATORY TRACT INFECTIONS AND DISEASES WITH GLUTATHION COMPOSITIONS
ES3008699T3 (en) 2017-11-17 2025-03-24 Renovion Inc Stable ascorbic acid compositions and methods of using the same
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
BR112021007692A2 (pt) * 2018-10-23 2021-08-10 George Edward Hoag composição e método para tratar os pulmões
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
IT202000009553A1 (it) 2020-04-30 2021-10-30 Innbiotec Pharma S R L Composizione farmaceutica di derivati del glutatione per l’uso nel trattamento di sindromi respiratorie
CN113252896B (zh) * 2021-05-13 2022-08-09 四川大学华西医院 一款利用肺泡灌洗液中nd1预测急性呼吸窘迫综合征预后的试剂盒
AU2023205178B2 (en) 2022-01-04 2025-09-25 Renovion, Inc. Aqueous solution comprising a glutathione salt

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA909679A (en) * 1972-09-12 Calbiochem Process of and composition for mucolysis
BE788945A (da) * 1971-09-20 1973-03-19 Oreal
US4424216A (en) * 1979-07-31 1984-01-03 The Rockefeller University Method for the reduction of mucin viscosity
DK283180A (da) * 1980-07-01 1982-01-02 Novo Industri As Polypeptider og derivater deraf
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
IT1176983B (it) * 1984-10-16 1987-08-26 Zambon Spa Dipeptidi ad attivita' farmacologica
GB8505285D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Compounds
US4710489A (en) * 1985-04-22 1987-12-01 Cornell Research Foundation, Inc. Glutathione delivery system
JP2770970B2 (ja) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー ペンタミジンを含有する医薬組成物

Also Published As

Publication number Publication date
JPH0669957B2 (ja) 1994-09-07
GR3015530T3 (en) 1995-06-30
DE69018092T2 (de) 1995-07-27
EP0502054A1 (en) 1992-09-09
EP0502054A4 (en) 1993-02-24
US5989521A (en) 1999-11-23
ATE120087T1 (de) 1995-04-15
CA2069440A1 (en) 1991-05-25
DE69018092D1 (de) 1995-04-27
EP0502054B1 (en) 1995-03-22
WO1991007997A1 (en) 1991-06-13
US5238683A (en) 1993-08-24
AU631711B2 (en) 1992-12-03
AU6885791A (en) 1991-06-26
JPH05501263A (ja) 1993-03-11
ES2069755T3 (es) 1995-05-16

Similar Documents

Publication Publication Date Title
DK0502054T3 (da) Aerosolfremstilling af glutathion og fremgangsmåde til forøgelse af glutathioninholdet i lunger
ATE402957T1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
DK57391A (da) Hiv proteiner og peptider til anvendelse ved diagnosticering, profylakse og behandling af aids
DE69928006D1 (de) Lagerstabile flüssige zusammensetzungen von glucagon-ähnlichem peptid-1
NO950668L (no) Peptider avledet fra et retrovirus fra HIV-gruppen og anvendelser derav
BG100974A (en) Vaccines against papillomavirus
NO20100324L (no) Fremgangsmate for trinnvis festing av polyetylenglykol (PEG) andeler i serie til et polypeptid
UA39174C2 (uk) Асоціати депротонованої гіалуронової кислоти, спосіб одержання асоціатів депротонованої гіалуронової кислоти, фармацевтична композиція та спосіб одержання фармацевтичної композиції
EP0184309A3 (en) Peptides selected from amino-acid residues 11 to 23 of vip
DK0423302T3 (da) Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner
WO1998044936A3 (de) Stabiler extrakt aus hypericum perforatum l., verfahren zu seiner herstellung und pharmazeutische zubereitungen
ATE206139T1 (de) Verfahren zur modifizierung der stabilität von antikörpern
IE872333L (en) Combinations of gamma-linolenic acid and calcium
DK610888D0 (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
DK0681470T3 (da) Sammensætning af rekombinant, levende subunitvaccine og fremgangsmåde til fremstilling heraf
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
DK0506836T3 (da) BCRF1 proteiner som inhibitorer for interferon-gamma
ATE254176T1 (de) Erhöhte produktion von beta-galaktosidase in aspergillus oryzae
IS3359A7 (is) ""2-guanidino-thiazol", aðferð til framleiðslu þess og notkun sem milliafurð við framleiðslu "famotidine" (N-sulfamyl-3-[(2-guanidinothiazol-4-yl)methylthio] -propionamidine)"
DE3471244D1 (en) Chair
NO900920L (no) Aprotinin-homologer og fremgangsmaate ved fremstilling av aprotinin og aprotininhomologer i gjaer.
NO923333L (no) Vasoaktive vasotocinderivater
UA37217C2 (uk) Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, фармацевтична композиція та проміжні сполуки
NO900926L (no) Substituerte (kinolin-2-yl-metoksy)fenyl-n,n'-sulfonylurinstoffer, deres fremstilling og anvendelse i legemidler.
DK0490383T3 (da) Peptider af HIV-gag-proteinet, fremstilling og anvendelse deraf